"If a BTD is granted the possible outcomes are (a) conditional or full approval, (b) expedited development, (c) rolling submission, or (d) review shortened."
In the last video, NP said that the FDA might give them approval to sell the drug, he would not risk with the FDA if they did not support them for such a request.